Physician profile
Roger P Thomas
NPI 1760474712
$1,413.26
in general payments reported to CMS, 2019-2025
23 companies · $13.73 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $203 · 2021: $575 · 2022: $251 · 2023: $102 · 2025: $13.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $201.61 | 2019-2023 | Repatha |
| Collegium Pharmaceutical, INC. | $187.39 | 2019-2023 | Xtampza, Belbuca |
| Biodelivery Sciences International, INC. | $185.53 | 2019-2021 | |
| Amarin Pharma, INC. | $116.89 | 2020-2021 | |
| Pfizer INC. | $111.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $97.14 | 2021-2023 | Verquvo |
| Medtronic, INC. | $65.54 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Almatica Pharma LLC | $56.12 | 2021 | |
| Lilly USA, LLC | $46.23 | 2020-2021 | |
| Abbvie INC. | $44.04 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $40.31 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $38.75 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.95 | 2019-2020 | |
| Radius Health, INC. | $31.77 | 2021 | |
| Ibsa Pharma INC. | $21.98 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $20.59 | 2023 | Vyepti |
| Depuy Synthes Sales INC. | $20.55 | 2021 | |
| Bioventus LLC | $19.89 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $19.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.25 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.82 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.02 | 2021 | |
| Daiichi Sankyo INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.